Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure.

Jeffrey M Testani, Meredith A Brisco, Jeffrey M Turner, Erica S Spatz, Lavanya Bellumkonda, Chirag R Parikh, W H Wilson Tang

March 2014 Circ Heart Fail

Synopsis of Social media discussions

Overall, discussions reflect recognition of the article's significance, mentioning specific researchers like Jeff Testani and the broader idea of how stress responses inform prognosis, with phrases such as 'how well your kind responds' indicating a focus on clinical relevance and future implications.

A
Agreement
 Moderate agreement

Most discussions acknowledge the relevance of diuretic response as a prognostic marker, with some endorsing the importance of the new metric.

I
Interest
 High level of interest

The topic garners high interest because it relates to kidney function and heart failure outcomes, which are significant clinical concerns.

E
Engagement
 Moderate level of engagement

Discussions include references to specific researchers and related concepts like stress responses, indicating moderate engagement.

I
Impact
 Moderate level of impact

The conversation suggests the research could influence clinical approaches to managing acute heart failure, though it is still in the research phase.

Social Mentions

YouTube

2 Videos

Twitter

1 Posts

Blogs

2 Articles

Metrics

Video Views

1,002

Total Likes

26

Extended Reach

4,296

Social Features

5

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Empagliflozin: Impact on Cardiovascular Health in Diabetic Patients

Empagliflozin: Impact on Cardiovascular Health in Diabetic Patients

Empagliflozin, a type 2 diabetes medication, reduces cardiovascular deaths and overall mortality in high-risk patients. This video explores the results of recent studies highlighting its effectiveness compared to placebo, along with considerations for patient safety.

Cardioflash College

September 3, 2021

629 views

Congestive Heart Failure Treatment in Chronic Kidney Disease Patients

Congestive Heart Failure Treatment in Chronic Kidney Disease Patients

This video discusses the treatment of congestive heart failure in patients with chronic kidney disease. It also addresses an erratum regarding blood pressure terminology at minute 08:33 of the Spanish version. For more details, refer to the listed references.

Cardioflash College

September 3, 2021

374 views

  • Jay Koyner
    @jaykoyner (Twitter)

    @NephroGuy @RossNesbit @Nephro_Sparks @LiverQs @hswapnil @Rommedinho @ssfarouk @FH_Verbrugge similar concepts - for sure. Jeff Testani and his collaborators have been looking at this for a long time. how well your kind responds to stresses (diuretics in this case or protein loads) can tell you a lot about your prognosis https://t.co/jSTelCYSSQ https://t.co/g84LQWli6f
    view full post

    February 20, 2021

    2

Abstract Synopsis

  • This study introduces a new way to measure how effectively kidneys can produce urine after diuretic medication, called diuretic efficiency (DE), which may provide better prognostic information than just looking at urine output or drug dose.
  • Analyzing two patient groups, researchers found that low DE was independently linked to worse survival rates, even after accounting for other health factors and diuretic doses.
  • Overall, DE appears to be a valuable marker for predicting long-term outcomes in patients hospitalized with acute heart failure, offering insights beyond traditional clinical measurements.]